Pfizer Attacked Over Lipitor Licensing Pact

Law360, New York (November 8, 2006, 12:00 AM EST) -- Astellas Pharma Inc. has hit pharmaceutical giant Pfizer Inc. with a lawsuit, hoping to assert its purported right to market the blockbuster cholesterol drug Lipitor in Japan.

On Tuesday, Astellas filed suit at the Tokyo District Court, asking the court to weigh in on a dispute over when the duo’s marketing agreement involving Lipitor expires.

The Japanese company currently sells Lipitor under a previously established licensing agreement with Pfizer.

The contract is supposed to be valid until the expiration of the drug's patents, which cover Lipitor's...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.